Atlas Trials

Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia

Clinical trial NCT04334850 · COMPLETED

Trial details

NCT number
NCT04334850
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Covid19Pneumonia
Start date
2020-04-20
Primary completion
2020-12-20
Enrollment
194

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.